RE: Approval22 Jan 2021 13:28
The real question for me is the relationship between IMM and Avion ...
The FDA should give approval for the P3 trial , that’s not the problem ...but will they give the The go ahead on the terms requested by Avion , that’s another matter ...
My major worry is Avion and not the FDA ....
I think IMM and Avion will come to some compromise about the funding of the trial , if the FDA have requested a larger patient cohort than what the Avion budget of $25 is covering
All speculation on my part so DYOR